Secondary prevention in a cardiology group practice and hospital setting after a heart-care initiative

This publication has 23 references indexed in Scilit:

• Comparative cost-effectiveness of HMG-CoA reductase inhibitors in secondary prevention of acute myocardial infarction
  American Journal of Health-System Pharmacy, 1999
• Achieving National Cholesterol Education Program Goals for Low-Density Lipoprotein Cholesterol in Cardiac Patients:Importance of Diet, Exercise, Weight Control, and Drug Therapy
  Mayo Clinic Proceedings, 1999
• Cost-effectiveness of 3-Hydroxy-3-Methylglutaryl–Coenzyme A Reductase Inhibitors in the Secondary Prevention of Cardiovascular Disease
  Archives of internal medicine (1960), 1999
• Physician Noncompliance With the 1993 National Cholesterol Education Program (NCEP-ATPII) Guidelines
  Circulation, 1998
• Persistence of Use of Lipid-Lowering Medications
  JAMA, 1998
• Performance Assessment Model for Guideline-Recommended Pharmacotherapy in the Secondary Prevention of Coronary Artery Disease and Treatment of Left Ventricular Dysfunction
  The American Journal of Cardiology, 1997
• Effect of fluvastatin on low-density lipoprotein peak particle diameter
  The American Journal of Cardiology, 1997
• The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
  New England Journal of Medicine, 1996
• Preventing heart attack and death in patients with coronary disease
  Journal of the American College of Cardiology, 1995
• National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II).
  Circulation, 1994